KORU Medical Systems, Inc. (KRMD) stock
KRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 13/30
$3.70+0.01 (+0.27%)
Close on Nov 13, 2026Market cap $170.84MP/E –Yield –
KORU Medical Systems r&d expenses
Research and development expenses are spending on new products and technology.
KORU Medical Systems's R&D Expenses for the twelve months ending Sep 30, 2026 was $4.81M, up 10.4% year over year. For fiscal 2025 it was $4.39M, down 16.6% from the year before. Over ten years it grew 35.0% a year on average. The highest annual figure on record is $5.74M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.39M | -16.6% |
| FY2024 | Dec 31, 2024 | $5.26M | -8.4% |
| FY2023 | Dec 31, 2023 | $5.74M | +15.9% |
| FY2022 | Dec 31, 2022 | $4.96M | +100.4% |
| FY2021 | Dec 31, 2021 | $2.47M | +90.8% |
| FY2020 | Dec 31, 2020 | $1.30M | +75.1% |
| FY2019 | Dec 31, 2019 | $740.48K | +211.8% |
| FY2017 | Feb 28, 2017 | $237.49K | +14.6% |
| FY2016 | Feb 29, 2016 | $207.28K | -55.7% |
| FY2015 | Feb 28, 2015 | $468.15K | +114.6% |
| FY2014 | Feb 28, 2014 | $218.15K | +47.8% |
| FY2013 | Feb 28, 2013 | $147.58K | +63.4% |
| FY2012 | Feb 29, 2012 | $90.33K | +154.3% |
| FY2011 | Feb 28, 2011 | $35.52K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $1.28M | +37.3% |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $1.07M | -10.5% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $1.32M | +18.1% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $1.14M | +2.7% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $933.11K | -39.2% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $1.19M | +5.3% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $1.11M | -24.5% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $1.11M | -13.5% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $1.53M | +18.6% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $1.13M | -29.0% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $1.48M | -5.7% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $1.29M | -21.6% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $1.29M | +50.0% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $1.60M | +22.5% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $1.56M | +36.3% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $1.64M | +387.5% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $862.15K | +144.8% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $1.30M | +233.9% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $1.15M | +285.1% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $336.84K | +31.6% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $352.12K | +21.4% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $390.42K | +129.3% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $298.20K | +67.3% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $256.03K | +151.1% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $290.02K | +437.2% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $170.26K | +187.9% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $178.24K | +163.3% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $101.96K | +79.9% |
| Q4 FY2017CQ1 2017 | Feb 28, 2017 | $53.99K | -14.8% |
| Q3 FY2017CQ4 2016 | Nov 30, 2016 | $59.14K | +14.7% |
| Q2 FY2017CQ3 2016 | Aug 31, 2016 | $67.69K | +74.8% |
| Q1 FY2017CQ2 2016 | May 31, 2016 | $56.67K | +5.6% |
| Q4 FY2016CQ1 2016 | Feb 29, 2016 | $63.34K | +3.1% |
| Q3 FY2016CQ4 2015 | Nov 30, 2015 | $51.56K | -55.9% |
| Q2 FY2016CQ3 2015 | Aug 31, 2015 | $38.71K | -75.6% |
| Q1 FY2016CQ2 2015 | May 31, 2015 | $53.67K | – |
| Q4 FY2015CQ1 2015 | Feb 28, 2015 | $61.45K | – |
| Q3 FY2015CQ4 2014 | Nov 30, 2014 | $116.89K | – |
| Q2 FY2015CQ3 2014 | Aug 31, 2014 | $158.42K | – |
See a number that looks wrong?